JAGUAR HEALTH, INC. Current Liabilities
JAGUAR HEALTH, INC. (JAGX) had Current Liabilities of $25.38 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-19
- 2026-06-30: Liabilities, Current $25.38M.
- 2026-03-31: Liabilities, Current $40.69M.
- 2025-12-31: Liabilities, Current $40.65M.
- 2025-09-30: Liabilities, Current $36.12M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $25.38M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $40.69M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $40.65M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $36.12M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $29.22M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $28.21M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $19.70M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $19.87M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $19.13M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $17.81M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $13.99M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $12.46M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $29.00M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $31.10M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $30.34M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $26.94M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $22.90M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $19.09M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $15.47M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $11.95M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $12.65M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $12.59M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $13.22M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $25.77M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $24.76M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $16.27M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $15.39M 10-K · filed 2021-03-31 | $15.39M 10-K · filed 2020-04-03 |
| 2019-09-30 | $8.57M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $20.84M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $24.75M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $26.66M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $16.14M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $12.37M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $9.38M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $15.39M 10-K · filed 2019-04-10 | |
| 2017-09-30 | $16.03M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $10.36M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $8.43M 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | $4.19M 10-K · filed 2018-04-09 | |
| 2016-09-30 | $3.10M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.95M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.69M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.91M 10-K · filed 2017-02-15 | |
| 2015-09-30 | $3.82M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $2.74M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $9.21M 10-Q · filed 2015-06-26 | |
| 2014-12-31 | $3.48M 10-K · filed 2016-03-29 | $3.56M 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |